Oncotarget

Research Papers:

Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancer

Hong Zhang, Yafei Zhang, Xixi Zhao, Xingcong Ma, Wanjun Yan, Wen Wang, Zitong Zhao, Qian Yang, Xi Sun, Hui Luan, Xiaoyan Gao and Shuqun Zhang _

PDF  |  HTML  |  Order a Reprint

Oncotarget. 2017; 8:46969-46980. https://doi.org/10.18632/oncotarget.16443

Metrics: PDF 617 views  |   HTML 724 views  |   ?  


Abstract

Hong Zhang1, Yafei Zhang2, Xixi Zhao1, Xingcong Ma1, Wanjun Yan1, Wen Wang1, Zitong Zhao1, Qian Yang1, Xi Sun3, Hui Luan4, Xiaoyan Gao1 and Shuqun Zhang1

1Department of Oncology, Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi, China

2Department of General Surgery, Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi, China

3Department of Integrated Traditional Chinese and Western Medicine, Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi, China

4Department of Cardiology, First Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi, China

Correspondence to:

Shuqun Zhang, email: 15229326653@163.com

Keywords: cancer, rs895819, rs6505162, meta-analysis

Received: November 30, 2016    Accepted: February 27, 2017    Published: March 22, 2017

ABSTRACT

Many studies have been conducted to investigate the association between miR-27 rs895819 A > G and miR-423 rs6505162 C > A and cancer risk; however, the results are not consistent. In order to acquire a more precise assessment of the correlation, we performed this meta-analysis. We searched PubMed, EMBASE and Web of Science databases to identify eligible studies. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were applied to evaluate the correlation of these two microRNA polymorphisms with cancer risk. Forty-five eligible studies from thirty-five articles were included in our analysis. The results showed that rs895819 was associated with a decreased cancer risk in Caucasians (AG vs. AA: OR = 0.87, 95% CI = 0.79-0.96; GG+AG vs. AA: OR = 0.89, 95% CI = 0.81-0.98). When grouped by ethnicity, an increased risk was observed in colorectal cancer (G vs. A: OR = 1.19, 95% CI = 1.08-1.32; GG vs. AA: OR = 1.58, 95% CI = 1.28-1.96; GG vs. AG+AA: OR = 1.58, 95% CI = 1.29-1.93), while a decreased risk was found in breast cancer (G vs. A: OR = 0.93, 95% CI = 0.87-0.99; GG+AG vs. AA: OR = 0.91, 95% CI = 0.83-0.99). For rs6505162, a significantly decreased cancer risk was observed in lung cancer under all five genetic models. To summarize, our results indicated that rs895819 was a protective factor for cancer in Caucasians and could increase colorectal cancer risk but decrease breast cancer risk. Moreover, rs6505162 was a protective factor for lung cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 16443